Eyelash growth drug used in conjunction with dermal fillers

Sales of a drug used to treat glaucoma are up 40 per cent, thanks to the lash-plumping side effects. Dr David Jordan, an ophthalmologist practising in Ottawa, Canada, released the figures in an interview with CBC News, and revealed that the drug was proving popular among men and women looking for fuller, thicker eyelashes. Asked why he thought sales had soared, Dr Jordan said: “They say the eyes are the window on the soul. Thicker, darker eyelashes are a sign of beauty, look back at Cleopatra.”Jordan, who uses the eye drops himself, told reporters that his patients had begun to combine the lash-boosting drug with non-surgical treatments such as Botox and dermal fillers to reduce the appearance of fine lines and wrinkles around the eyes. See original story here: http://www.cbc.ca/news/health/story/2012/06/18/ottawa-eyelash-drug-latisse-sales-jump-due-to-length-and-volume.html